SEC Form 4 · accession 0001209191-17-012363
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Bradley Cole
Officer — COO
Period of report
Feb 15, 2017
Accepted (ET)
Feb 17, 2017 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 15, 2017 | M | 5,000 | $23.31 | A | 48,022 | D | |
| Common StockF1,F2,F3 | Feb 15, 2017 | S | 5,000 | $29.00 | D | 43,022 | D | |
| Common StockF4 | Feb 15, 2017 | F | 3,294 | $31.12 | D | 39,728 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $23.31 | Feb 15, 2017 | M | 5,000 | D | — | Dec 6, 2017 | Common Stock | 0 | 5,710 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2016.
- F2Represents actual sale price.
- F3Includes an aggregate of 26,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F4Includes an aggregate of 18,174 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F5The option became exercisable as to 25% of the shares on December 6, 2008, and became exercisable as to 1/48th of the shares each full month thereafter.